Simon Stanworth, NHSBT Consultant Haematologist, receives 2026 Tibor Greenwalt Memorial Award

18 November 2026

Simon Stanworth, one of our NHSBT principal investigators, has received the 2026 Tibor Greenwalt Memorial Award in recognition of his research career trying to answer the common question "Doctor, what good will this transfusion do me?".

This major award is given by the Association for the Advancement of Blood & Biotherapies (AABB), a leading international society for blood transfusion, for 'exemplary contributions to transfusion medicine and advancements in patient outcomes worldwide'.

Simon is an NHS Blood and Transplant Consultant Haematologist. He is also a professor of haematology and transfusion medicine at the Radcliffe Department of Medicine, University of Oxford.

The award citation noted Simon has been an author on over 600 published studies. His research has been centred on determining which patients really require a transfusion and if the benefits outweigh the risks.

"One of my achievements has been practice-changing randomised national and international trials to answer this question," he said.

What research has Simon been involved in?

One trial established whether it's necessary to give prophylactic platelet transfusions to prevent bleeding in all patients with blood cancers.

A further trial of platelet transfusions in small infants indicated that babies who received more platelet transfusions did worse, supporting the need to recommend more restrictive strategies.

He has worked for trials in major bleeding, cryoprecipitate use in major trauma, and prehospital whole-blood transfusion.

Other studies include trials of 'alternatives' to transfusions, such as tranexamic acid and iron.

The current 'PANDA' trial is testing whether routinely taking iron supplements during pregnancy can prevent anaemia, reducing the risk of stillbirth and other serious or potentially fatal complications.

In total, he has been involved in more than 35 national and international randomised trials - many still ongoing - working with many different research teams and other organisations national and internationally.

Simon is also now the first Director of the NIHR Blood Transfusion Research Unit (BTRU) in 'Data Enabled' Transfusion Practice, a partnership between NHSBT and the University of Oxford.

Another theme of his work is putting research into practice, for example in collaborations to develop international guidelines to provide clear recommendations based on evidence. His other leadership positions include Chair of the European Haematology Association Transfusion

Specialist Working Party, Chair of the International Collaboration for Transfusion Medicine Guidelines, and co-Chair for the clinical studies team for the Biomedical Excellence for Safer Transfusion Collaborative (BEST).

Simon said: "It is an unbelievable honour to be recognized for the work I have done. For me, it is about many wonderful and enriching partnerships and collaborations with different individuals and teams in NHSBT, nationally and internationally."